RESUMEN
Rubia cordifolia represents the pivotal plant resource belonging to traditional Chinese medicine and Indian Ayurveda. The present study aims to synthesize biocompatible copper oxide nanoparticles (CuONPs) using R. cordifolia bark extracts, characterize the incumbent chemical transitions, and explore their biomedical and environmental applications. The absorbance peak between 250 and 300 nm clearly demonstrates the formation of CuONPs in the UV-visible spectrum. Fourier transform infrared spectroscopy results showed the presence of functional groups essential for copper ion reduction. Field emission scanning electron microscopy (FE-SEM) and dynamic light scattering analysis revealed that the CuONPs are spherical-shaped with a mean particle size of 50.72 nm. Additionally, the zeta potential demonstrates its robustness at 11.2 mV. X-ray diffraction pattern showed mixed phases (Cu, Cu2O, and CuO) of cubic monoclinic crystalline nature. CuONPs exhibited noticeable antibacterial activity against Gram-negative (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus and Bacillus cereus) pathogenic bacteria. Bacterial cell damages were affirmed through FE-SEM imaging when treated with CuONPs. Further, CuONPs demonstrated considerable antioxidant activities by quenching free radicals such as DPPH (60.75%), ABTs (70.88%), nitric oxide (65.48%) and reducing power (71.44%) in a dose-dependent way. CuONPs showed significant larvicidal activity against Aedes aegypti (65 ± 8.66%), Anopheles stephensi (80 ± 13.69%), and Culex quinquefasciatus (72 ± 13.04%) mosquito larvae. The photocatalytic activity of the CuONPs demonstrates the methylene blue (81.84%) and crystal violet (64.0%) dye degradation potentials, indicating the environmental bioremediation efficacy. Hence the present study is the first report in accounting for the versatile applications of the phyto-CuONPs. Moreover, the green synthesis of CuONPS has future applications in designing the drug for life-threatening diseases and various environmental issues.
Asunto(s)
Anopheles , Nanopartículas del Metal , Rubia , Animales , Antioxidantes , Cobre/química , Corteza de la Planta , Nanopartículas del Metal/química , Antibacterianos/química , Óxidos , Extractos Vegetales/química , Espectroscopía Infrarroja por Transformada de FourierRESUMEN
Acinetobacter baumannii (A. baumannii) is one of the major representative aetiologies of recalcitrant nosocomial infections. Genotypic and phenotypic alterations in A. baumannii have resulted in a significant surge in multidrug resistance (MDR). Of all the factors responsible for the development of antimicrobial resistance (AMR), efflux protein pumps play a paramount role. In pursuit of a safe alternative for the prevention and control of A. baumannii infections, bioactive compounds from the aerial parts of the medicinal plant Artemisia pallens were studied. GC-MS analysis of the ethanol extract of A. pallens detected five major compounds: lilac alcohol A, spathulenol, lilac alcohol C, n-hexadecanoic acid, and vulgarin. In silico examinations were performed using the Schrödinger suite. Homology modelling was performed to predict the structure of the efflux protein of A. baumannii-LAC-4 strain (MDR Ab-EP). The identified bioactive compounds were analysed for their binding efficiency with MDR Ab-EP. High binding efficiency was observed with vulgarin with a glide score of -4.775 kcal/mol and stereoisomers of lilac alcohol A (-3.706 kcal/mol) and lilac alcohol C (-3.706 kcal/mol). Our molecular dynamic simulation studies unveiled the stability of the ligand-efflux protein complex. Vulgarin and lilac alcohol A possessed strong and stable binding efficiency with MDR Ab-EP. Furthermore, validation of the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of the ligands strongly suggested that these compounds could serve as a lead molecule in the development of an alternate drug from A. pallens.